🔍 Two influential viewpoints just dropped in JAMA Cardiology on aortic valve replacement (AVR) in asymptomatic severe aortic stenosis (AS).

🫀 Lindman, Braunwald & Pellikka argue that the time has come to move from "watchful waiting" to early intervention (SAVR/TAVR), citing RCTs showing reduced stroke, heart failure hospitalization, and unplanned CV events.

⚖️ Hillis, McCann & Newby counter that the evidence is not yet strong enough for a universal shift—pointing to trial limitations, competing risks in older patients, and the danger of unnecessary procedures.

✨ The debate is clear: Act early or wait carefully?

This conversation is shaping the future of valve guidelines and clinical practice.